Sumant Kulkarni

Stock Analyst at Canaccord Genuity

(0)
# 4715
Out of 5,319 analysts
124
Total ratings
12.50%
Success rate
-24.54%
Average return
25 Stocks
Name Action Price Target Current % Upside Ratings Updated
CRVO CervoMed
Maintains: Strong Buy
12 21
9.91 111.91% 5 Mar 18, 2025
ZVRA Zevra Therapeutics
Maintains: Strong Buy
23 25
7.15 249.65% 6 Mar 13, 2025
VYGR Voyager Therapeutics
Maintains: Buy
14 12
3.15 280.95% 5 Mar 13, 2025
CMPS Compass Pathways
Maintains: Buy
23 15
3.12 380.77% 3 Feb 28, 2025
BIIB Biogen
Maintains: Buy
298 265
118.57 123.5% 15 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
9 8
7.43 7.67% 5 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
86 73
7.31 898.63% 7 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
172 163
101.36 60.81% 14 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
119 132
n/a n/a 5 Jan 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
112 80
1.76 4445.45% 7 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 28
9.05 209.39% 4 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 11
1.48 643.24% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
86 83
3 2666.67% 5 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
5.79 141.8% 1 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
360 36
5.32 576.69% 4 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 20
7.7 159.74% 3 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 26
1.23 2013.82% 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 33
14.71 124.34% 13 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 2
n/a n/a 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Sep 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Jan 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
101 150
20.41 634.93% 4 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
20
n/a n/a 4 Sep 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
110 120
n/a n/a 2 Feb 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Jan 31, 2017